|
|
|
European Biopharmaceutical Review
|
Jean de La Fontaine said that one often meets his fate on the path he takes to avoid it. Fate is perhaps too deterministic a word for the scientific phenomenon of antimicrobial resistance (AMR), but there is growing concern that the drive to eliminate harmful microbes from human environments could be having the opposite effect.
So far, scientists have only managed to induce resistance to antimicrobial technologies in the laboratory, but it will become a possibility in the wild if antimicrobial technologies are used irresponsibly.
The potential for ‘over-protecting’ ourselves by overusing antimicrobial technologies has likely been exacerbated by the COVID-19 pandemic, and, in an ironic twist of fate, the desire to avoid dangerous disease could in fact make it inevitable. While the pandemic presents a clear need for antimicrobial technologies and more efficient sanitation, a careful balance will need to be found, to prevent a catastrophic turn of events.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
India Toomey is an Editor and Copywriter at IDTechEx. She covers a broad range of topics, from life science to haptics and electric vehicles. At IDTechEx, India manages the editing and publishing of analyst reports, company profiles, and premium articles. Recent works include No Lives at Steak: How Will Your Food be Made in the Future? and Your Kids Won’t Learn to Drive, and Here’s Why.
Dr Nadia Tsao is a Principal Analyst at IDTechEx where she has been driving the company’s research in life science. Her research spans a range of topics within healthcare, including digital health, bioelectronic medicine, and tissue engineering. At IDTechEx, Nadia has authored research reports and articles, delivered custom consulting projects to multibillion-dollar companies, taught masterclasses, and co-organised the company’s Healthcare Sensor Innovations conference and exhibition.
|
|
|
India Toomey |
|
|
|
|
Dr Nadia Tsao |
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Aptar Pharma Completes First Phase of Global Expansion Program to Meet Growing Customer Capacity Needs for Injectable Drug Delivery
Crystal Lake, Illinois, October 31, 2022 - Aptar Pharma, a global
leader in drug delivery systems, services and active material science
solutions, today announced that it has delivered the first phase of its
previously announced expansion program of approximately $180 million USD
to meet growing customer capacity needs for injection system solutions.
The multisite, international expansion project began in 2020 and is
intended to significantly boost capacity across all product lines,
ultimately enabling Aptar Pharma to produce over 10 billion injectable
component units annually when completed.
More info >> |
|
 |
White Papers |
 |
|
The Key To Tableting Success: How To Choose The Right Tooling
Natoli Engineering Company, Inc.
Choosing the right tooling can increase tablet output, decrease waste and ultimately determine the success of a product launch.
More info >> |
|
|
